Industrias Gobar S.A. de C.V. wrote:
>
> -----Original Message-----
> From: Industrias Gobar S.A. de C.V. <gobar@riogrande.net.mx>
> To: mol-cancer@meds.com <mol-cancer@meds.com>
> Date: Friday, November 28, 1997 1:08 PM
> Subject: Re: Help me please
>
> -----Original Message-----
> From: Industrias Gobar S.A. de C.V. <gobar@riogrande.net.mx>
> To: mol-cancer@meds.com <mol-cancer@meds.com>
> Date: Wednesday, November 26, 1997 1:49 PM
> Subject: Help me please
>
> hi
> I need your help please send me information fot the treatment of a 60 years old men with 140lbs and 5.5' of heigth that has glioblastoma multiple diagnosed in Juanary 97' , i have the knowledge that the "Talidomida" is a medicine wich helps to this problem but a i need to know the dose for this treatment if you have any information about this please send it to me because i have this medicine but i have not the dose.
> If you have any other treatment for this illneess please let me know and thank you so much
>
> Regards
>
> Erica Rodriguez
>
> gobar@riogrande.net.mx
> H. Matamoros, Tamaulipas, Mexico.
>
>
My dear neighbor in Mexico,
Pls contact HOag Memorial HOspital in Newport Beach, Cal or U.C.L.A. in
Los Angeles, Cal. neurosurgery dept for details and other opinions on
this form of brain tumor and disease. It is being successfully treated
in some at these facilities.
If you wish information as to phone numbers and addresses, pls contact
me and I will get them and the name of the doctors for you.
God Bless You
Marty and Barb Auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
